Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen.

Three-dimensional (3D) culture of cancer cell lines has long been advocated as a better model of the malignant phenotype that is most closely related to tumorigenicity in vivo. Moreover, new drug development requires simple in vitro models that resemble the in vivo situation more in order to select active drugs against solid tumours and to decrease the use of experimental animals. A biodegradable, biocompatible and non-toxic polymer chitosan was employed for 3D culture of MCF-7 cell lines. Cells grown on chitosan scaffold produce more lactate from glucose in comparison to that secreted by cells grown on tissue culture plate, thus indicating the suitability of chitosan scaffold as an in vitro model resembling cancer tissue growth in vivo. Cytotoxic effect of tamoxifen at different concentrations was evaluated for MCF-7 breast cancer cell lines grown on tissue culture plate as well as on 3D chitosan scaffold. At a tamoxifen concentration of 10(-6) M, 50% reduction in cell growth was observed in tissue culture plate-grown cells where 15% reduction in cell growth was observed when cells were grown in chitosan scaffold. Higher tamoxifen concentrations were required to achieve comparable cytostatic action in 3D culture, supporting the fact that 3D culture is a better model for the cytotoxic evaluation of anticancer drugs in vitro. Carbohydrate metabolism of MCF-7 cells in terms of glucose utilization and lactate production in 3D and monolayer culture were unaffected by tamoxifen treatment. Cathepsin D activity, an autocrine growth factor in breast cancer cells was monitored in all experiments. In 3D culture, addition of tamoxifen promoted cathepsin D secretion but inhibited its uptake by cells. Growth of cells in 3D chitosan scaffold indicated that action of tamoxifen on estrogen positive cancer cells is also mediated through inhibition of cathepsin D uptake from the culture medium.

[1]  V. Jordan Chemoprevention with Antiestrogens: The Beginning of the End for Breast Cancer , 2001, Annals of the New York Academy of Sciences.

[2]  S. Madihally,et al.  Porous chitosan scaffolds for tissue engineering. , 1999, Biomaterials.

[3]  R. Muzzarelli,et al.  Reconstruction of parodontal tissue with chitosan. , 1989, Biomaterials.

[4]  N. Davidson,et al.  The role of estrogens in growth regulation of breast cancer. , 1989, Critical reviews in oncogenesis.

[5]  M J Bissell,et al.  Dynamic reciprocity revisited: a continuous, bidirectional flow of information between cells and the extracellular matrix regulates mammary epithelial cell function. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[6]  F. May,et al.  Cathepsin D and breast cancer. , 1996, European journal of cancer.

[7]  V. Jordan The Past, Present, and Future of Selective Estrogen Receptor Modulation , 2001, Annals of the New York Academy of Sciences.

[8]  V. Jordan,et al.  Selective Estrogen Receptor Modulation , 2001 .

[9]  R. Dickson,et al.  Mechanisms of normal and malignant breast epithelial growth regulation. , 1989, Journal of steroid biochemistry.

[10]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[11]  H. Rochefort,et al.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. , 1989, Cancer research.

[12]  F. Grinnell Cellular adhesiveness and extracellular substrata. , 1978, International review of cytology.

[13]  D. Zava,et al.  Estrogen receptor-mediated and cytotoxic effects of the antiestrogens tamoxifen and 4-hydroxytamoxifen. , 1984, Cancer research.

[14]  I. Taylor,et al.  Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. , 1983, Cancer research.

[15]  S. Green Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[16]  F. Miller,et al.  Significance of three-dimensional growth patterns of mammary tissues in collagen gels , 1983, In Vitro.

[17]  Z. Shao,et al.  Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. , 1992, Cancer research.

[18]  P. Pujol,et al.  Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency. , 1990, Oncogene.

[19]  A. Abbott Cell culture: Biology's new dimension , 2003, Nature.

[20]  Mina J Bissell,et al.  Modeling tissue-specific signaling and organ function in three dimensions , 2003, Journal of Cell Science.

[21]  N. Gebbia,et al.  Kinetics of in vivo inhibition of tissue cathepsin D by pepstatin A. , 1988, The International journal of biochemistry.

[22]  G. Giaccone,et al.  The multilayered postconfluent cell culture as a model for drug screening. , 2000, Critical reviews in oncology/hematology.

[23]  V. Jordan,et al.  Selective Estrogen Receptor Modulation : A Personal Perspective 1 , 2001 .

[24]  Robert A. Weinberg,et al.  Taking the Study of Cancer Cell Survival to a New Dimension , 2002, Cell.

[25]  H. Rochefort Cathepsin D in breast cancer , 1990, Breast Cancer Research and Treatment.

[26]  F. Miller,et al.  Factors affecting growth and drug sensitivity of mouse mammary tumor lines in collagen gel cultures. , 1985, Cancer research.

[27]  H. Rochefort,et al.  Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[28]  C. Larabell,et al.  Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: a different perspective in epithelial biology. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Mazzucchelli,et al.  Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancer. , 2003, The American journal of pathology.

[30]  Kenneth M. Yamada,et al.  Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.

[31]  C. Anderson,et al.  E7-transduced human breast epithelial cells show partial differentiation in three-dimensional culture. , 1999, Cancer research.

[32]  Marcel Garcia,et al.  Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells , 2002, Oncogene.

[33]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.

[34]  A. Ray,et al.  Characterization and evaluation of chitosan matrix for in vitro growth of MCF-7 breast cancer cell lines. , 2004, Biomaterials.

[35]  V. Jordan Biochemical pharmacology of antiestrogen action. , 1984, Pharmacological reviews.

[36]  L. Mazzucchelli,et al.  Cathepsin D Specifically Cleaves the Chemokines Macrophage Inflammatory Protein-1α, Macrophage Inflammatory Protein-1β, and SLC That Are Expressed in Human Breast Cancer , 2003 .

[37]  R. Hoffman Three-dimensional histoculture: origins and applications in cancer research. , 1991, Cancer cells.